BIOTRONIK Successfully Completes Testing of BIOTRONIK EHR DataSync®- Connecting BIOTRONIK Home Monitoring® to Electronic Health Record Systems
During the week of January 9, 2012, BIOTRONIK participated in the "Integrating the Healthcare Enterprise" (IHE) North American Connectathon in Chicago, Illinois, to test its implantable device cardiac observation (IDCO) profile. This testing1 demonstrated the ability of BIOTRONIK Home Monitoring®to connect to third-party electronic health record (EHR) systems and cardiovascular data management systems using defined industry standards. The connecting technology from the BIOTRONIK Home Monitoring®system to the EHRs is called BIOTRONIK EHR DataSync®.
The conclusion from this successful testing is that BIOTRONIK EHR DataSync® will enable physicians and hospitals to share data seamlessly, which should increase productivity, eliminate redundant medical device management systems and improve clinical decision making and quality of care. In this round of testing, BIOTRONIK proved the ability of BIOTRONIK EHR DataSync® to connect with widely implemented EHR vendor systems (e.g., Epic and Medical Micrographics), as well as emerging and established cardiovascular data management systems (e.g., ScottCare's OneView(TM) CRM).
The IHE developed their testing process to promote the adoption of standards that enable healthcare information to be shared seamlessly across clinical settings. The IHE's goals are to drive standards for interoperability, to increase efficiency, and to reduce costs to healthcare customers, such as those in the cardiology, radiology and laboratory markets.
About BIOTRONIK EHR DataSync®
Implantable cardiac devices are also designed to capture and record information about medical device performance and patient heart rhythms that is vital to patient care. BIOTRONIK Home Monitoring®quickly organizes this information and allows data to be sent directly and securely to a clinic's or a hospital's EHR system. That data is then available to include in the patient's personal health record.
"Electronic health records support efficient access to important patient healthcare information, so making this data readily available via secure data transport is vital," said Jake Langer, President of BIOTRONIK, Inc. "Streamlined connectivity to critical device and lead data is an increasingly important priority for physicians and the broader U.S. healthcare network, and therefore BIOTRONIK made it a priority too. This demonstration of our system's broad capabilities proves BIOTRONIK's willingness and ability to provide yet another breakthrough, best-in-class innovation in accessing patient information."
Data integrity is guaranteed and has been proven through validation testing. Data security is ensured by using U.S. Commerce Department encryption methods. In addition, the BIOTRONIK Home Monitoring®system adheres to patient privacy standards and requirements for the electronic transmission of health information in accordance with the Health Insurance Portability and Accountability Act of 1996 (HIPAA) standards.
About BIOTRONIK Home Monitoring®
BIOTRONIK Home Monitoring® is the first and only remote patient management system with FDA approval to replace device interrogation during in-office follow-up visits. BIOTRONIK Home Monitoring® allows for the safe reduction of conventional clinic follow-up visits and early detection of patient clinical events, based on results of the TRUST landmark trial.2-3
The system is unique because it allows continuous, automatic, wireless remote monitoring of patient and device status with daily updates-all independent from any patient interaction.
With immediate access to patient information through the secure BIOTRONIK Home Monitoring® website, physicians can remotely monitor and assess patient device data and determine the level of care needed. Alert notifications can be customized to fit each clinic's workflow, helping to optimize clinic efficiency.
BIOTRONIK Home Monitoring® has pioneered advances in remote patient management since its first U.S. clinical application in 2001. Today, BIOTRONIK Home Monitoring® is extensively used with a growing number of patients in more than 3,800 clinics and 55 countries worldwide.
1 Data on file.
2 Varma N et al., Circulation, 2010, 122, 325-332.
3 Varma N et al., Circ Arrhythm Electrophysiol, 2010, 3:428-436.
As one of the world's leading manufacturers of cardiovascular medical devices, with several million devices implanted, BIOTRONIK is represented in over 100 countries by its global workforce of over 5,600 employees. Known for having its finger on the pulse of the medical community, BIOTRONIK assesses the challenges physicians face, and provides the best solutions for all phases of patient care, ranging from diagnosis to treatment to patient management. Quality, innovation and reliability define BIOTRONIK and its growing success, and deliver confidence and peace of mind to physicians and their patients worldwide.
More information: www.biotronik.com